2025 ATA Thyroid Cancer Guidelines- what's New for Surgeons

Saturday, October 17, 2026

4:00 PM - 5:00 PM PT

Location: 501AC

Panelist(s)

Amanda L. Karcioglu, MD

Clinical Assistant Professor, Pritzker School of Medicine University of Chicago
Endeavor Health / University of Chicago
Skokie, IL, Illinois, United States

Moderator(s)

chau T. nguyen, MD

Director, Division of Otolaryngology-Head & Neck Surgery
Anacapa Surgical Associates
Ventura, California, United States

Panelist(s)

scharpf joseph, MD

Professor of Otolaryngology-Head and Neck Surgery
Cleveland Clinic
Chagrin Falls, Ohio, United States

The American Thyroid Association (ATA) has published an updated 2025 management guidelines for adult patients with differentiated thyroid cancer (DTC). Herein we highlight the key updates and differences between the two versions emphasizing those most pertinent to endocrine neck surgeons. These guidelines will form the basis for differentiated thyroid cancer care over the next few years, affecting millions of patients. For maximal impact, they will need to be widely disseminated, discussed and dissected, to ultimately result in practice changes befitting the latest evidence-based care.

Learning Objectives:

Describe changes from the original 2015 ATA guidelines task force framework
List new additions to the 2025 ATA guidelines
Identify key updates in the latest ATA guidelines